ECCO IBD Curriculum
11.1.A. Understands the importance of comorbidities and history of previous malignancy in relation to IBD and possible treatment patient might require.
This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to IBD and Malignancies and to harmonise diagnostics and treatment in order to improve patient outcomes.
This course will follow the following cases on:
- Colorectal cancer in IBD
- Lymphoma risk following immunosuppressive therapy with thiopurines in IBD patients - cancer and IBD
- Skin cancer in IBD
- Chemotherapy in chronically active ulcerative colitis
Upon completion of this activity learners will have gained knowledge on:
- IBD and Solid Tumours
- IBD and Haematological Malignancies
- IBD and Skin Malignancies
- Management of IBD patients with a past history of malignancy
This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). The intended result of this activity is increased competence, knowledge, performance and improved patient outcomes.
Upon completion of this activity learners will:
- Identify patients at risk of opportunistic infections and understand the principles of screening for opportunistic infections
- Understand the issues associated with vaccinating people at risk of opportunistic infections
- Be familiar with the assessment and management of some of the more commonly encountered and serious opportunistic infections (HBV, TB, VZV, CMV etc.)
- Understand requirements for people with IBD when travelling and returning from travel
- Recognise the opportunistic infections which should be considered in acute flares of colitis